About Diaverum
Diaverum is a Healthcare company based in Munchen (Germany) founded in 2007, and was acquired by M42 in April 2023. It operates as a dialysis treatments are delivered via a network of specialized clinics. Diaverum has raised $28.46 million across 3 funding rounds from investors including CPP Investments, Bridgepoint Capital and European Union. Diaverum has completed 1 acquisition, including Advance Renal Care. Its website diaverum.com draws about 38 thousand monthly visits. Diaverum offers products and services including d.CARE App, d.HOLIDAY Program, and Haemodialysis Service. Its focus areas include Clinic Chains, Specialty Clinics and Dialysis Clinics. Its legal entity is Diaverum Deutschland GmbH. Its competitors include Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim.
Company details
Diaverum was established in 2007 and is headquartered in Munich, Germany. Operations focus on the healthcare sector, specifically renal care, through a chain of dialysis clinics. Services include hemodialysis and related treatments for patients with kidney conditions. The network spans multiple locations, with emphasis on clinical care and patient management in Europe and beyond. Expansion has been pursued to enhance accessibility in the dialysis field.
- Total Equity Funding$28.46M (USD)
in 3 rounds
- Latest Funding Round$842.63K (USD), Grant
Jan 2018
- InvestorsCPP Investments
& 4 more
- Investments & Acquisitions
- Acquired by
Products & Services of Diaverum
Diaverum offers a comprehensive portfolio of products and services, including d.CARE App, d.HOLIDAY Program, and Haemodialysis Service.
App empowering patients with chronic kidney disease management tools.
Program facilitating dialysis access for patients traveling internationally.
Treatment removing toxins from blood for kidney failure patients.
Apps and channels of Diaverum
its YouTube channel Diaverum Global has 1.46K subscribers and 30 videos.
Videos from Diaverum
The most watched videos on Diaverum's YouTube channel, Diaverum Global (1.46K subscribers). Click a video to play it here.
More on Diaverum Global.
Funding Insights of Diaverum
Diaverum has successfully raised a total of $28.46M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $842.63 thousand completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.46M
- Total Rounds 3
- Last Round Grant — $842,632
- Investors Count 3
All 3 funding rounds of Diaverum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $842,632 | Grant | – | – | |
| Sep 2007 | $28.46M | Private Equity Round | – | – | |
| Jun 2007 | – | Private Equity Round | – | CPP Investments | – |
5 investors in total: 5 institutional.
Investors in Diaverum
Diaverum has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include CPP Investments, Bridgepoint Capital and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed across multiple sectors. | – | atp-pep.com | Copenhagen, Denmark | |
Middle-market businesses up to €1 billion are acquired pan-Europe. | 1984 | bridgepoint.eu | Frankfurt, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Pension fund assets are managed for sustainable long-term growth. | 1997 | cppinvestments.com | Toronto, Canada | |
Provider of integrated healthcare solutions for diagnosis purpose | 2023 | m42.ae | Abu Dhabi, United Arab Emirates |
Investor details for Diaverum
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Diaverum
80 people are tracked at Diaverum (32 in leadership, 48 in team).
| Name | Role | Group |
|---|---|---|
Monica Morera | 🌍global Director Of Talent Attraction And Employer Branding - Digital Platforms (healthcare) | Leadership |
Valeria Gigli | Human Resources Director | Leadership |
Carlos Lucas | Vice President Medical Diaverum | Leadership |
Fernando MacÁrio | Chief Medical Officer | Leadership |
Imed Helal M.D., Ph.D., Fisn | Medical Director | Leadership |
Sergio Gustavo Rodriguez | Director Of Operations Europe Latam | Leadership |
Vicki Dobson | Operations Director | Leadership |
Mohammed al-Abadi | Head Of Employee Services | Leadership |
Carlos Carpintero | HR Director Diaverum Spain | Leadership |
Percival Holmes | HR Director | Leadership |
Sven Havelius | Corporate HR Director | Leadership |
Yvonne Lo | Human Resources Director | Leadership |
Helen Buck | Human Resources Business Partner | Leadership |
Julius Adam Huckabee | Director, Business Insights | Leadership |
Patricia Fors | Vice President Human Resources Europe, Latam And Global HR Operations | Leadership |
Zulfiqar Ali | Medical Director | Leadership |
Carla Santos | Corporate Medical Director | Leadership |
Osvaldo Hermida | Medical Director | Leadership |
Gamal Fathy Abdalla Ahmed | Medical Director | Leadership |
Jurgita Uogintaite | Country Medical Director | Leadership |
60 more people are available in the full profile.
Complete people profiles for Diaverum
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diaverum
Diaverum has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Advance Renal Care.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A chain of dialysis clinics is operated in Singapore. | advancerenalcare.com.sg | Singapore | 2011 | Nov 2020 | •••• |
Complete acquisition details for Diaverum
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Diaverum
6 dated milestones of Diaverum across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Diaverum is founded.
- Exit Acquired by Bridgepoint Capital.
- Funding First funding round.
- Funding Latest funding round, Grant, of $843K.
- Acquisition Acquires Advance Renal Care.
- Exit Acquired by M42.
Competitors of Diaverum
Diaverum has 2 listed competitors in our database. They include Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nierenzentrum-wertheim.de | 2000 | – | – | – | Operates a chain of dialysis clinics providing essential renal care services. | |
| nierenzentrum-tauberbischofsheim.de | 2000 | Stuttgart, Germany | – | – | Operates a chain of dialysis clinics providing essential services. |
Detailed competitors of Diaverum
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Diaverum
The website of Diaverum (diaverum.com) receives about 38.3K visits a month.
- Monthly visits38.3K
▲ 55% vs previous month
Websites whose visitors overlap most with Diaverum. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nephrocare.pt | nephrocare.pt | 100% | – | – | – |
| usrenalcare.com | 87% | 36.4K | #898,488 | View details | |
| americanrenal.com | 87% | – | – | View details | |
nkfs.org | nkfs.org | 67% | – | #972,718 | – |
| efpia.eu | 50% | 89.3K | #445,999 | View details |
Top companies in Hospitals & Clinical Care
10 companies that operate in the same segment as Diaverum (Hospitals & Clinical Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 8,400 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 | |
Multispeciality secondary and tertiary care is provided by hospital chains. | 1999 | Secunderabad, Telangana, India | USD 62.46 M | USD 416.2 M | 6,490 | |
Multispecialty hospitals are operated as a chain in India. | 2001 | Delhi, Delhi, India | – | USD 889.96 M | 26,830 | |
Multi-specialty hospitals and surgery centers are operated nationwide. | 1968 | Nashville, Tennessee, United States | USD 97.27 M | USD 75.6 B | 316,000 | |
Standalone veterinary clinics are operated for pet care services. | 2017 | New York, New York, United States | USD 98.5 M | – | – | |
Healthcare services, research, education, and community support are provided. | 1942 | United States | – | – | – | |
Provider of tech-heavy clinics for multiple healthcare solutions for patients | 2017 | Brooklyn, New York, United States | USD 1.02 B | – | 785 | |
Multispecialty hospitals are operated as a chain in India. | 1991 | Bengaluru, Karnataka, India | USD 645.32 M | USD 1.1 B | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diaverum
Complete news archive for Diaverum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diaverum
Diaverum was founded in 2007.
Diaverum is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Diaverum is a funded company, having raised a total of $28.46M across 3 funding rounds to date.
Diaverum was established in 2007 and is headquartered in Munich, Germany. Operations focus on the healthcare sector, specifically renal care, through a chain of dialysis clinics. Services include hemodialysis and related treatments for patients with kidney conditions. The network spans multiple locations, with emphasis on clinical care and patient management in Europe and beyond. Expansion has been pursued to enhance accessibility in the dialysis field.
Diaverum's top competitors include Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim.
Diaverum offers d.CARE App, d.HOLIDAY Program, and Haemodialysis Service.
Diaverum has made 1 acquisition, including Advance Renal Care.
Diaverum has 5 investors. Key investors include CPP Investments, Bridgepoint Capital, European Union, M42, and ATP Private Equity Partners.
Diaverum operates through Diaverum Deutschland Gmbh.
Yes. Diaverum was acquired by M42 in April 2023.